Longevity Insights
Evidence-based perspectives on longevity medicine, healthspan, and the everyday systems that shape how well you live. Short enough to use, serious enough to trust, and always connected to a physician-led view.
The Maximum Life Newsletter
Longevity made clear, personal, and executable.
Short notes from the TML team: research signals, practical context, and physician-led perspective for people who want more good years — without wellness noise.
No spam. Unsubscribe anytime.
Filter Articles

Menopause, Hormone Therapy, and Longevity
Menopause affects sleep, mood, metabolism, bone strength, body composition, brain function, cardiovascular health, and quality of life. Hormone therapy is not a one-size-fits-all answer, but it belongs in a serious, personalized longevity conversation.

The Smarter Way to Fly
Flying can disrupt circadian rhythm, hydration, movement, sleep, and metabolic routines. A few small, strategic choices can help you land clearer, sleep better, and recover faster.

Sleep Is When the Brain Does Its Repair Work
Good sleep supports far more than next-day energy. It helps regulate metabolism, inflammation, hormones, memory, and the brain’s nightly housekeeping systems. Here is why sleep belongs at the center of any serious longevity plan.

Mitochondria and Longevity: Why Cellular Energy Matters as We Age
Mitochondria are often described as cellular power plants, but for longevity they are more than energy producers. They sit at the center of metabolism, inflammation, brain function, muscle health, and resilience. Here is how to think about mitochondrial health without turning it into supplement hype.

Hormesis: Why the Right Kind of Stress Can Support Longevity
Hormesis is the idea that small doses of challenge can make the body more resilient. Exercise, heat, cold, and fasting may all work partly through this principle — but only when the dose matches the person and recovery is protected.

Senolytics Are Moving From Proof of Concept to Early Human Signals
Senolytics target senescent cells, a biologically active cell state linked to inflammation, tissue dysfunction, and aging-related disease. The promise is real—but so are the risks, unknowns, and need for physician-led precision.

Fasting, Spermidine, and mTOR: The Autophagy Axis Behind Cellular Repair
Fasting, spermidine, and rapamycin are often discussed separately. Emerging research suggests they may converge on autophagy and nutrient-sensing pathways—but clinical translation requires caution, context, and personalization.

GLP-1s, Peptides, and Longevity: What’s Real Beyond the Hype
GLP-1 medications have changed metabolic medicine because they are supported by clinically meaningful human outcomes, not because they are “longevity hacks.” Here’s how to think clearly about peptide therapeutics, evidence tiers, muscle preservation, monitoring, and physician-led personalization.

Rapamycin and mTOR: What the Evidence Actually Says
mTOR biology has matured from elegant mechanism to serious translational platform. But the responsible conclusion is not rapamycin for everyone — it is precision, context, and clinical supervision.

Polyphenols, Sea Vegetables, and Food as Biological Signal
Polyphenols and sea vegetables are useful not because they are superfoods, but because food carries signals that influence metabolism, inflammation, vascular health, and the gut.

Partial Cellular Reprogramming: Frontier Science, Not Protocol
Partial cellular reprogramming may eventually change how medicine thinks about aging. For now, it is powerful frontier science — not an available consumer protocol.
Showing 1-12 of 24 articles
